601 related articles for article (PubMed ID: 22879951)
21. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine.
Rockman S; Brown LE; Barr IG; Gilbertson B; Lowther S; Kachurin A; Kachurina O; Klippel J; Bodle J; Pearse M; Middleton D
J Virol; 2013 Mar; 87(6):3053-61. PubMed ID: 23283953
[TBL] [Abstract][Full Text] [Related]
22. Multiple-clade H5N1 influenza split vaccine elicits broad cross protection against lethal influenza virus challenge in mice by intranasal vaccination.
Yang P; Duan Y; Zhang P; Li Z; Wang C; Dong M; Tang C; Xing L; Gu H; Zhao Z; Liu X; Zhang S; Wang X
PLoS One; 2012; 7(1):e30252. PubMed ID: 22279575
[TBL] [Abstract][Full Text] [Related]
23. A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
Kistner O; Crowe BA; Wodal W; Kerschbaum A; Savidis-Dacho H; Sabarth N; Falkner FG; Mayerhofer I; Mundt W; Reiter M; Grillberger L; Tauer C; Graninger M; Sachslehner A; Schwendinger M; Brühl P; Kreil TR; Ehrlich HJ; Barrett PN
PLoS One; 2010 Feb; 5(2):e9349. PubMed ID: 20186321
[TBL] [Abstract][Full Text] [Related]
24. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
[TBL] [Abstract][Full Text] [Related]
25. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets.
Chen Z; Kim L; Subbarao K; Jin H
Vaccine; 2012 Mar; 30(15):2516-22. PubMed ID: 22330124
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination.
Lin HT; Chuang CC; Wu HL; Chu DM; Wang YC
J Biomed Sci; 2013 Mar; 20(1):19. PubMed ID: 23517052
[TBL] [Abstract][Full Text] [Related]
27. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
Matassov D; Cupo A; Galarza JM
Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
[TBL] [Abstract][Full Text] [Related]
28. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y
Virol J; 2010 Jul; 7():151. PubMed ID: 20624292
[TBL] [Abstract][Full Text] [Related]
29. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
[TBL] [Abstract][Full Text] [Related]
30. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
Quan FS; Vunnava A; Compans RW; Kang SM
PLoS One; 2010 Feb; 5(2):e9161. PubMed ID: 20161790
[TBL] [Abstract][Full Text] [Related]
31. A pandemic H1N1 influenza virus-like particle vaccine induces cross-protection in mice.
Inn KS; Lee GJ; Quan FS
Immunol Invest; 2014; 43(3):236-54. PubMed ID: 24354853
[TBL] [Abstract][Full Text] [Related]
32. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
[TBL] [Abstract][Full Text] [Related]
33. Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase.
Skarlupka AL; Zhang X; Blas-Machado U; Sumner SF; Ross TM
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680224
[TBL] [Abstract][Full Text] [Related]
34. Transient humoral protection against H5N1 challenge after seasonal influenza vaccination of humans.
Roozendaal R; Tolboom J; Roos A; Riahi S; Theeuwsen J; Bujny MV; Klaren V; Korse HJ; Dekking L; Grootenhuis A; Weverling GJ; Koudstaal W; Goudsmit J; Radošević K
PLoS One; 2014; 9(7):e103550. PubMed ID: 25075622
[TBL] [Abstract][Full Text] [Related]
35. Pandemic H1N1 influenza virus-like particles are immunogenic and provide protective immunity to pigs.
Pyo HM; Masic A; Woldeab N; Embury-Hyatt C; Lin L; Shin YK; Song JY; Babiuk S; Zhou Y
Vaccine; 2012 Feb; 30(7):1297-304. PubMed ID: 22207090
[TBL] [Abstract][Full Text] [Related]
36. Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
Easterbrook JD; Schwartzman LM; Gao J; Kash JC; Morens DM; Couzens L; Wan H; Eichelberger MC; Taubenberger JK
Virology; 2012 Oct; 432(1):39-44. PubMed ID: 22727831
[TBL] [Abstract][Full Text] [Related]
37. Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.
Skarlupka AL; Owino SO; Suzuki-Williams LP; Crevar CJ; Carter DM; Ross TM
Hum Vaccin Immunother; 2019; 15(9):2013-2029. PubMed ID: 31448974
[TBL] [Abstract][Full Text] [Related]
38. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
[TBL] [Abstract][Full Text] [Related]
39. Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
Tretyakova I; Hidajat R; Hamilton G; Horn N; Nickols B; Prather RO; Tumpey TM; Pushko P
Virology; 2016 Jan; 487():163-71. PubMed ID: 26529299
[TBL] [Abstract][Full Text] [Related]
40. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
